Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
5.30
+0.02 (0.38%)
May 6, 2026, 3:00 PM CST

SHA:600713 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,0494,5632,3722,3282,095
Trading Asset Securities
215.28----
Cash & Short-Term Investments
3,2644,5632,3722,3282,095
Cash Growth
-28.45%92.39%1.87%11.13%41.32%
Accounts Receivable
16,28915,09816,20919,30415,251
Other Receivables
-165.19-129.2329.7129.2822.86
Receivables
16,12414,96816,23819,33415,274
Inventory
6,9046,2865,7985,7874,518
Other Current Assets
2,1201,9911,6051,8131,571
Total Current Assets
28,41227,80826,01329,26123,458
Property, Plant & Equipment
2,0041,8851,5071,5191,492
Long-Term Investments
269.24283.47237.64206.45254.18
Goodwill
63.2472.1772.1772.1772.17
Other Intangible Assets
209.49215.68218.98245.28268.11
Long-Term Deferred Tax Assets
271.27243.43222.82224.93180.78
Long-Term Deferred Charges
98.2663.0743.3436.8934.24
Other Long-Term Assets
103.18102.7495.5884.69126.24
Total Assets
31,43030,67428,41031,65125,886
Accounts Payable
11,09810,1769,69410,1318,064
Accrued Expenses
335.81369.49363.63438.32379.33
Short-Term Debt
4,7593,7604,5748,4147,036
Current Portion of Long-Term Debt
195.14900.982,2231,409-
Current Portion of Leases
82.8979.6376.0471.6878.28
Current Income Taxes Payable
174.1387.691.48102.89136.01
Current Unearned Revenue
333.99278.67103.57219.1274.78
Other Current Liabilities
1,5421,4411,4411,4981,756
Total Current Liabilities
18,52017,09418,56622,28417,525
Long-Term Debt
4,1465,3392,1182,2222,628
Long-Term Leases
192.07116.18119.02103.23124.4
Long-Term Unearned Revenue
260.79277.62297.06293.17304.61
Long-Term Deferred Tax Liabilities
58.0459.0555.4154.2469.9
Total Liabilities
23,17822,88621,15524,95620,652
Common Stock
1,3091,3091,3101,3101,042
Additional Paid-In Capital
2,4542,4662,4602,4291,380
Retained Earnings
3,3752,9732,6112,2171,778
Treasury Stock
-51.33-20.9-35.9-38.58-
Comprehensive Income & Other
98.5111.2489.7281.98406.6
Total Common Equity
7,1856,8386,4356,0004,606
Minority Interest
1,068949.87819.73695.03627.46
Shareholders' Equity
8,2537,7887,2556,6955,234
Total Liabilities & Equity
31,43030,67428,41031,65125,886
Total Debt
9,37510,1969,11012,2199,867
Net Cash (Debt)
-6,111-5,634-6,738-9,891-7,772
Net Cash Per Share
-4.17-4.32-5.19-7.89-7.46
Filing Date Shares Outstanding
1,3091,3091,3101,3101,042
Total Common Shares Outstanding
1,3091,3091,3101,3101,042
Working Capital
9,89110,7147,4476,9785,933
Book Value Per Share
5.495.224.914.584.42
Tangible Book Value
6,9126,5506,1445,6824,266
Tangible Book Value Per Share
5.285.004.694.344.10
Buildings
1,4521,4631,1331,1661,046
Machinery
962.26928.24890.32839.29762.13
Construction In Progress
349.69237.27130.0880.23153.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.